For Dutch tram operator HTM, today marks the start of passenger services with brand new Siemens trams in The Hague, Netherlands. The first Avenio will run on line 2, which connects the western suburb of Kraayenstein with Leidschendam in the northeast via The Hague's main station. The Siemens trams will also gradually progress to operating on lines 1, 9, 15 and 17, with test runs already being conducted on the next route earmarked for Avenio, line 11. HTM has ordered a total of 60 Avenio trams from Siemens.
"Before commencing passenger services, we carried out extensive tests, as we make no compromise when it comes to safety. I am very satisfied with the results, and very proud of our employees for their hard work and dedication. I would like to thank the metropolitan region of Rotterdam The Hague (MRDH) and all the local authorities involved for making this step forward possible.
I would also like to take the opportunity to express my appreciation to the manufacturer, Siemens, for having achieved these results. Siemens has built the trams according to our requirements and wishes – and it is now time for our passengers to take over," says Jaap Bierman, CEO of HTM.
"The Hague is the second city to operate passenger services with our trams. The test runs have already shown that the Avenio is well-equipped for this city's tram network, which is in service more than 150 years. By virtue of its exceptionally smooth and quiet operating profile, it is ultimately passengers who will benefit the most from the Avenio," adds Sandra Gott-Karlbauer, CEO of Urban Transport at Siemens.
The Hague is carrying out extensive structural work along the lines to enable operation of the new low-floor trams, with tracks being renewed and all stops to receive new, specially adapted tram platforms. More than half of the tracks and stops have already been converted to accommodate the new trams.
For further information on Mobility Division, please see www.siemens.com/mobility
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry.
The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 343,000 employees worldwide on a continuing basis.
Further information is available on the Internet at www.siemens.com
Reference Number: PR2015110059MOEN
Ms. Ellen Schramke
Tel: +49 (30) 386-22370
Ellen Schramke | Siemens Mobility
New players, standardization and digitalization for more rail freight transport
16.07.2018 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)
A helping (Sens)Hand
11.04.2018 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy